Back

Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure

30 August 2024 (16:00 - 16:30)
Organised by: Logo
Congress Presentation Part of: Biomarkers in acute heart failure: latest findings Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Emmanuel Scatularo

Buenos Aires (Argentina)

5 More presentations in this session

Presentation thumbnail
Prognostic value of alveolar surfactant type-B in acute heart failure: a long-term comparative analysis vs NT-proBNP
Associate Professor F. Bursi (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Eicosanoids in coronary sinus negatively correlate with natriuretic peptides in heart failure with reduced ejection fraction: insights from Eicosanoids in Human Heart Failure Study
Doctor P. Kala (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
The association between circulating B cell count and clinical outcomes in patients with heart failure
Doctor Y. Kobayashi (Yamagata, JP)
Abstract Slides Video
Presentation thumbnail
The dynamics of urine sodium concentration after intra-venous furosemide in patients with acute heart failure
Doctor Y. Fujimoto (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Changes in N-terminal pro b-type natriuretic peptide according to SGLT2 inhibitor utilization patterns in patients hospitalized for decompensated heart failure: a prospective cohort study
Doctor P. Theofilis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers in acute heart failure: latest findings

The Event

Event poster

ESC Congress 2024

30 August 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
Early assessment of diuretic resistance: predictive factors and impact on outcomes of patients with acute heart failure.
thumbnail
Congress Presentation
Monitoring diuretic efficacy in heart failure: detection of resistance and treatment algorithms
thumbnail
Congress Presentation
The best strategies in refractory patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources